Shares of Moderna Inc. /zigman2/quotes/205619834/composite MRNA -4.45% shed 1.08% to $273.39 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ Composite Index /zigman2/quotes/210598365/realtime COMP -2.72% rising 0.44% to 15,845.23 and the Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA -1.30% falling 0.03% to 35,804.38. This was the stock's second consecutive day of losses. Moderna Inc. closed $224.10 below its 52-week high ($497.49), which the company reached on August 10th.
The stock underperformed when compared to some of its competitors Wednesday, as AbbVie Inc. /zigman2/quotes/202428675/composite ABBV -0.79% fell 0.19% to $118.66, Amgen Inc. /zigman2/quotes/209157011/composite AMGN -0.52% fell 0.27% to $203.97, and AstraZeneca PLC ADR /zigman2/quotes/200304487/composite AZN -1.78% fell 0.69% to $56.34. Trading volume (4.7 M) remained 7.7 million below its 50-day average volume of 12.4 M.